The biologic DMARDs rituximab and abatacept were associated with an increased risk for incident cancers in patients with RA ...

Request To Download Free Sample of This Strategic Report @- In addition, rise in patient awareness toward availability of various treatments for rheumatoid arthritis, increase in focus of ...

Rheumatoid arthritis arises when the immune system ... Rheumatoid factor can guide treatment decisions, allowing for a personalized approach to RA management. If you have high RF levels, you ...

CervoMed’s ex-Vertex drug has failed to reduce the severity of patients’ dementia in a phase 2 trial, halting plans for a ...

Higher MTX-PG concentrations were associated with improved disease activity among patients with RA receiving MTX therapy, though they were also linked to hepatotoxicity.

Patients with both RA and metabolic syndrome demonstrated lower response rates to TNF inhibitor and non-TNF inhibitor therapies.

Research reveals a higher cancer risk for rheumatoid arthritis patients using certain biologics, emphasizing the need for ...